Rank #1484PRME

Prime Medicine, Inc.

$3.33

1.22% (Daily)

Market Cap

$601.10M

Revenue

$5.98M

Rank by MCap

#1484

Sector

Healthcare

Industry

Biotechnology

CEO

Mr. Jeffrey D. Marrazzo M.B.A., M.P.A.

Headquarters

Cambridge, MA

Employees

214

About Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and ...